Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells.

Hoareau-Aveilla C, Quelen C, Congras A, Caillet N, Labourdette D, Dozier C, Brousset P, Lamant L, Meggetto F.

Haematologica. 2019 Feb;104(2):347-359. doi: 10.3324/haematol.2018.195131. Epub 2018 Sep 27.

2.

PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.

Jamrog L, Chemin G, Fregona V, Coster L, Pasquet M, Oudinet C, Rouquié N, Prade N, Lagarde S, Cresson C, Hébrard S, Nguyen Huu NS, Bousquet M, Quelen C, Brousset P, Mancini SJC, Delabesse E, Khamlichi AA, Gerby B, Broccardo C.

Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10357-10362. doi: 10.1073/pnas.1721678115. Epub 2018 Sep 26.

PMID:
30257940
3.

Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells.

Congras A, Caillet N, Torossian N, Quelen C, Daugrois C, Brousset P, Lamant L, Meggetto F, Hoareau-Aveilla C.

Oncotarget. 2018 Feb 8;9(18):14539-14551. doi: 10.18632/oncotarget.24465. eCollection 2018 Mar 6.

4.

Editor's Choice - A Study of the Cost-effectiveness of Fenestrated/branched EVAR Compared with Open Surgery for Patients with Complex Aortic Aneurysms at 2 Years.

Michel M, Becquemin JP, Marzelle J, Quelen C, Durand-Zaleski I; WINDOW Trial participants.

Eur J Vasc Endovasc Surg. 2018 Jul;56(1):15-21. doi: 10.1016/j.ejvs.2017.12.008. Epub 2018 Jan 17.

PMID:
29342417
5.

MYB-GATA1 fusion promotes basophilic leukaemia: involvement of interleukin-33 and nerve growth factor receptors.

Ducassou S, Prouzet-Mauléon V, Deau MC, Brunet de la Grange P, Cardinaud B, Soueidan H, Quelen C, Brousset P, Pasquet JM, Moreau-Gaudry F, Arock M, Mahon FX, Lippert E.

J Pathol. 2017 Jul;242(3):347-357. doi: 10.1002/path.4908. Epub 2017 May 29.

PMID:
28418072
6.

PERK mediates the IRES-dependent translational activation of mRNAs encoding angiogenic growth factors after ischemic stress.

Philippe C, Dubrac A, Quelen C, Desquesnes A, Van Den Berghe L, Ségura C, Filleron T, Pyronnet S, Prats H, Brousset P, Touriol C.

Sci Signal. 2016 May 3;9(426):ra44. doi: 10.1126/scisignal.aaf2753.

PMID:
27141928
7.

Clobazam and clonazepam use in epilepsy: Results from a UK database incident user cohort study.

Brodie MJ, Chung S, Wade A, Quelen C, Guiraud-Diawara A, François C, Verpillat P, Shen V, Isojarvi J.

Epilepsy Res. 2016 Jul;123:68-74. doi: 10.1016/j.eplepsyres.2016.04.003. Epub 2016 Apr 11.

8.

Key contribution of eIF4H-mediated translational control in tumor promotion.

Vaysse C, Philippe C, Martineau Y, Quelen C, Hieblot C, Renaud C, Nicaise Y, Desquesnes A, Pannese M, Filleron T, Escourrou G, Lawson M, Rintoul RC, Delisle MB, Pyronnet S, Brousset P, Prats H, Touriol C.

Oncotarget. 2015 Nov 24;6(37):39924-40. doi: 10.18632/oncotarget.5442.

9.

Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth.

Hoareau-Aveilla C, Valentin T, Daugrois C, Quelen C, Mitou G, Quentin S, Jia J, Spicuglia S, Ferrier P, Ceccon M, Giuriato S, Gambacorti-Passerini C, Brousset P, Lamant L, Meggetto F.

J Clin Invest. 2015 Sep;125(9):3505-18. doi: 10.1172/JCI78488. Epub 2015 Aug 10.

10.

RNA editing in acute myeloid leukaemia with normal karyotype.

Quelen C, Eloit Y, Noirot C, Bousquet M, Brousset P.

Br J Haematol. 2016 Jun;173(5):788-90. doi: 10.1111/bjh.13631. Epub 2015 Aug 7. No abstract available.

PMID:
26251186
11.

Editor's choice - thirty day outcomes and costs of fenestrated and branched stent grafts versus open repair for complex aortic aneurysms.

Michel M, Becquemin JP, Clément MC, Marzelle J, Quelen C, Durand-Zaleski I; WINDOW Trial Participants.

Eur J Vasc Endovasc Surg. 2015 Aug;50(2):189-96. doi: 10.1016/j.ejvs.2015.04.012. Epub 2015 Jun 19.

12.

Small nucleolar RNA expression profiles refine the prognostic impact of IGHV mutational status on treatment-free survival in chronic lymphocytic leukaemia.

Berquet L, Valleron W, Grgurevic S, Quelen C, Zaki O, Quillet-Mary A, Davi F, Brousset P, Bousquet M, Ysebaert L.

Br J Haematol. 2016 Mar;172(5):819-23. doi: 10.1111/bjh.13544. Epub 2015 Jun 11. No abstract available.

PMID:
26095450
13.

History of Antidepressant use Among Primary Care Depressed Patients Switching Treatments in the United Kingdom.

Lamy FX, Quelen C, Brignone M, Ferchichi S, Vataire AL, Rive B, Saragoussi D.

Value Health. 2014 Nov;17(7):A466. doi: 10.1016/j.jval.2014.08.1304. Epub 2014 Oct 26. No abstract available.

14.

Myeloid neoplasm with translocation t(2;11)(p21;q23-24), elevated microRNA 125b-1, and JAK2 exon 12 mutation.

McCormick SR, Higgins RR, Grutkoski PS, Bousquet M, Quelen C, Bartholomaus LM, Brousset P.

Br J Haematol. 2015 Apr;169(2):290-3. doi: 10.1111/bjh.13190. Epub 2014 Oct 15. No abstract available.

PMID:
25316507
15.

Cost-effectiveness of computed tomography coronary angiography versus conventional invasive coronary angiography.

Darlington M, Gueret P, Laissy JP, Pierucci AF, Maoulida H, Quelen C, Niarra R, Chatellier G, Durand-Zaleski I.

Eur J Health Econ. 2015 Jul;16(6):647-55. doi: 10.1007/s10198-014-0616-2. Epub 2014 Jul 3.

PMID:
24990117
16.

Comparison of two data collection processes in clinical studies: electronic and paper case report forms.

Le Jeannic A, Quelen C, Alberti C, Durand-Zaleski I; CompaRec Investigators.

BMC Med Res Methodol. 2014 Jan 17;14:7. doi: 10.1186/1471-2288-14-7.

17.

Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma.

Valleron W, Ysebaert L, Berquet L, Fataccioli V, Quelen C, Martin A, Parrens M, Lamant L, de Leval L, Gisselbrecht C, Gaulard P, Brousset P.

Blood. 2012 Nov 8;120(19):3997-4005. doi: 10.1182/blood-2012-06-438135. Epub 2012 Sep 18.

18.

Specific small nucleolar RNA expression profiles in acute leukemia.

Valleron W, Laprevotte E, Gautier EF, Quelen C, Demur C, Delabesse E, Agirre X, Prósper F, Kiss T, Brousset P.

Leukemia. 2012 Sep;26(9):2052-60. doi: 10.1038/leu.2012.111. Epub 2012 Apr 23.

PMID:
22522792
19.

B-cell regulator of immunoglobulin heavy-chain transcription (Bright)/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells.

Puissegur MP, Eichner R, Quelen C, Coyaud E, Mari B, Lebrigand K, Broccardo C, Nguyen-Khac F, Bousquet M, Brousset P.

Leukemia. 2012 Oct;26(10):2224-32. doi: 10.1038/leu.2012.95. Epub 2012 Apr 3.

PMID:
22469780
20.

Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas.

Caillard S, Lamy FX, Quelen C, Dantal J, Lebranchu Y, Lang P, Velten M, Moulin B; French Transplant Centers.

Am J Transplant. 2012 Mar;12(3):682-93. doi: 10.1111/j.1600-6143.2011.03896.x. Epub 2012 Jan 6.

21.

Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants.

Quelen C, Lippert E, Struski S, Demur C, Soler G, Prade N, Delabesse E, Broccardo C, Dastugue N, Mahon FX, Brousset P.

Blood. 2011 May 26;117(21):5719-22. doi: 10.1182/blood-2011-01-333013. Epub 2011 Apr 7.

22.

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.

Coyaud E, Struski S, Prade N, Familiades J, Eichner R, Quelen C, Bousquet M, Mugneret F, Talmant P, Pages MP, Lefebvre C, Penther D, Lippert E, Nadal N, Taviaux S, Poppe B, Luquet I, Baranger L, Eclache V, Radford I, Barin C, Mozziconacci MJ, Lafage-Pochitaloff M, Antoine-Poirel H, Charrin C, Perot C, Terre C, Brousset P, Dastugue N, Broccardo C.

Blood. 2010 Apr 15;115(15):3089-97. doi: 10.1182/blood-2009-07-234229. Epub 2010 Feb 16.

23.

Discontinuation of hormone therapy in the French GAZEL cohort 1990-2006.

Ringa V, Fritel X, Varnoux N, Zins M, Quelen C, Bouyer J.

Fertil Steril. 2010 Sep;94(4):1387-91. doi: 10.1016/j.fertnstert.2009.07.1001. Epub 2009 Sep 11.

PMID:
19748086
24.

PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study.

Familiades J, Bousquet M, Lafage-Pochitaloff M, Béné MC, Beldjord K, De Vos J, Dastugue N, Coyaud E, Struski S, Quelen C, Prade-Houdellier N, Dobbelstein S, Cayuela JM, Soulier J, Grardel N, Preudhomme C, Cavé H, Blanchet O, Lhéritier V, Delannoy A, Chalandon Y, Ifrah N, Pigneux A, Brousset P, Macintyre EA, Huguet F, Dombret H, Broccardo C, Delabesse E.

Leukemia. 2009 Nov;23(11):1989-98. doi: 10.1038/leu.2009.135. Epub 2009 Jul 9.

PMID:
19587702
25.

Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation.

Bousquet M, Quelen C, Rosati R, Mansat-De Mas V, La Starza R, Bastard C, Lippert E, Talmant P, Lafage-Pochitaloff M, Leroux D, Gervais C, Viguié F, Lai JL, Terre C, Beverlo B, Sambani C, Hagemeijer A, Marynen P, Delsol G, Dastugue N, Mecucci C, Brousset P.

J Exp Med. 2008 Oct 27;205(11):2499-506. doi: 10.1084/jem.20080285. Epub 2008 Oct 20.

26.

Long-term outcome of parenthood project during in vitro fertilization and after discontinuation of unsuccessful in vitro fertilization.

de La Rochebrochard E, Quelen C, Peikrishvili R, Guibert J, Bouyer J.

Fertil Steril. 2009 Jul;92(1):149-56. doi: 10.1016/j.fertnstert.2008.05.067. Epub 2008 Aug 15.

PMID:
18706550
27.

Association between premenopausal progestogen use and postmenopausal hormonal therapy in the GAZEL cohort.

Ringa V, Fritel X, Varnoux N, Zins M, Piault S, Quelen C.

Maturitas. 2007 Nov 20;58(3):216-25. Epub 2007 Oct 4.

PMID:
17919857
28.

CD5-positive diffuse large B cell lymphoma arising from a CD5-positive follicular lymphoma.

Vassallo J, Bousquet M, Quelen C, Al Saati T, Delsol G, Brousset P.

J Clin Pathol. 2007 May;60(5):573-5.

29.

A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5.

Bousquet M, Broccardo C, Quelen C, Meggetto F, Kuhlein E, Delsol G, Dastugue N, Brousset P.

Blood. 2007 Apr 15;109(8):3417-23. Epub 2006 Dec 19.

31.

The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene.

Bousquet M, Quelen C, De Mas V, Duchayne E, Roquefeuil B, Delsol G, Laurent G, Dastugue N, Brousset P.

Oncogene. 2005 Nov 3;24(48):7248-52.

PMID:
16091753

Supplemental Content

Loading ...
Support Center